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SUMMARY
The role of the neurovascular niche in CNS
myelin regeneration is incompletely understood.
Here, we show that, upon demyelination, CNS-resi-
dent pericytes (PCs) proliferate, and parenchymal
non-vessel-associated PC-like cells (PLCs) rapidly
develop. During remyelination, mature oligoden-
drocytes were found in close proximity to PCs. In
Pdgfbret/ret mice, which have reduced PC numbers,
oligodendrocyte progenitor cell (OPC) differentia-
tion was delayed, although remyelination pro-
ceeded to completion. PC-conditioned medium
accelerated and enhanced OPC differentiation
in vitro and increased the rate of remyelination
in an ex vivo cerebellar slice model of demyelin-
ation. We identified Lama2 as a PC-derived factor
that promotes OPC differentiation. Thus, the func-
tional role of PCs is not restricted to vascular
homeostasis but includes the modulation of
adult CNS progenitor cells involved in regen-
eration.
INTRODUCTION
Although the adult mammalian CNS has a limited capacity for
regeneration, lost oligodendrocytes and themyelin they produce
are restored during remyelination. In response to demyelination,
oligodendrocyte progenitor cells (OPCs) proliferate and migrate
to the lesion, where they differentiate into remyelinating oligo-
dendrocytes (Franklin and Ffrench-Constant, 2008; Zawadzka
et al., 2010). Remyelination restores saltatory conduction and
ensures axonal survival, and its impairment renders demyeli-
nated axons vulnerable to irreversible degeneration (Franklin
et al., 2012). Thus, promoting remyelination is a major therapeu-
tic objective in chronic demyelinating diseases such as multiple
sclerosis, where remyelination becomes increasingly inefficient
with disease progression (Goldschmidt et al., 2009).
Myelination during development is strictly coupled to angio-
genesis (Yuen et al., 2014), where OPCs use the vasculature
as scaffolds for migration (Tsai et al., 2016). Similarly, regenera-
tion in the CNS is coupled to the vascular niche (Manavski et al.,
2014). The CNS vascular niche consists of endothelial cells
(ECs), vasculature-associated cells such as perivascular cells,
astrocytes, neurons, OPCs, molecules derived from these cells,
and blood-derived elements. Pericytes (PCs), which are located
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Figure 1. Pericytes React to Demyelination
(A) Ethidium bromide-induced demyelinated lesion in the CCP of adult rats.
(B) PDGFRb expressing PC and RECA-1+ ECs in NAWM.
(legend continued on next page)
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at the abluminal surface of capillaries and embedded within the
basement membrane, regulate angiogenesis and neovasculari-
zation and control microvascular blood flow (Armulik et al.,
2010). The CNS contains the highest PC density in the body,
ensuring proper blood-brain barrier (BBB) structure and function
(Armulik et al., 2010;Winkler et al., 2011). CNS-resident PCs also
share features with mesenchymal stem cells (MSCs), expressing
similar genes and differentiating into cells of the mesenchymal
lineage in vitro (Crisan et al., 2008). MSCs secrete a plethora of
paracrine signaling molecules (Chen et al., 2009), including fac-
tors that promote oligodendrocyte differentiation (Jadasz et al.,
2013; Rivera et al., 2006). We hypothesized that PCs act in a
similar fashion (Lange et al., 2013). This assumption is supported
by the close physical proximity between PCs and OPCs in
healthy cerebral white matter (Maki et al., 2015) and by the ability
of PC-derived transforming growth factor b 1 to regulate OPC
migration during cortical development (Choe et al., 2014). Here
we analyzed PCs, their response to a demyelinating lesion,
and their functional role in oligodendrocyte differentiation during
remyelination. In vivo relevance was studied through a genetic
mouse model with reduced pericyte coverage. Moreover,
molecular and cellular analysis identified the PC-derived factor
modulating OPC differentiation.
RESULTS
Pericytes Respond to CNS Demyelination
We first analyzed the proliferative response and localization of
ECs and PCs following induction of white matter demyelination
upon injection of ethidium bromide into the caudal cerebellar
peduncles (CCPs) of adult rats (Figure 1A). In this model, demye-
lination occurs within 24 hr of injection and induces OPC prolifer-
ation and migration, which peaks at 5 days post-lesion induction
(dpl), followed by OPC differentiation, which is ongoing at 14 dpl.
Remyelination is completed by 21 dpl. There was a significant in-
crease in proliferating (Ki67-positive) rat endothelial cell antigen
1 (RECA-1)-expressing ECs and a robust proliferative response
of platelet-derived growth factor receptor beta (PDGFRb)-ex-
pressing PCs within the demyelinated lesion at 5 dpl (Figures
S1C and S1D), although the vessel area was not altered between
5 and 21 dpl (Figures S1A and S1B). In the normal-appearing
white matter (NAWM), PCs are restricted to the perivascular
region (Figure 1B). The total number of PDGFRb+ cells within
the lesion was significantly increased at 14 dpl compared with
NAWM (Figures 1C and 1D). This was accompanied by the
appearance of PDGFRb+ cells away from blood vessels, which,
because we cannot be certain of their origin, we defined as peri-
cyte-like cells (PLCs) to distinguish them fromPCs close to blood
vessels (Figure 1C). Within the whole PDGFRb+ population (i.e.,
PCs andPLCs), the proportion of PCs declined during remyelina-
tion (Figure 1E), whereas the percentage of parenchymal PLCs
increased and was highest at 14 dpl (Figure 1F). Consistent
with the unaltered density of ECs and PCs during remyelination
(Figures S1E and S1F), the EC:PC ratio, crucial for BBB stability
(Armulik et al., 2010), remained the same (Figure 1G). At 5 dpl,
there were numerous Ki67+ PDGFRb+ cells in the lesion that
peaked at 14 dpl but declined thereafter and were absent at
60 dpl (Figures 1H–1K). By 60 dpl, when the lesion is fully remye-
linated, PDGFRb+ cell numbers and localization were similar to
that in NAWM, where only PCs and no PLCs were found (Figures
1C–1G). Staining for desmin, another PC marker, supported
these findings (Figure S4A).
We hypothesized that, if PCs and/or PLCs were involved in the
differentiation of OPCs into remyelinating oligodendrocytes,
then the differentiated cells would tend to be located in close
proximity to PDGFRb+ cells. We therefore assessed the dis-
tance between Olig2+/adenomatous polyposis coli (APC)
OPCs and Olig2+/APC+ oligodendrocytes to the nearest
PDGFRb+ cell at 14 dpl. We found that oligodendrocytes were
preferentially located close (i.e., within 10 mm) to PCs, whereas
OPCs showed no preferential clustering close to these cells;
neither was there clustering of either OPCs or oligodendrocytes
close to PLCs (Figures 1L and 1M; Figures S1G and S1H). These
results suggest that PCs and PLCs may have differential roles in
modulating OPC function during remyelination.
Impaired Oligodendrocyte Differentiation during
Remyelination in PC-Deficient Mice
To determine whether CNS-resident PCs influence remyelina-
tion, we used Pdgfbret/ret mice, in which a mutation in the reten-
tion motif of the Pdgfb gene causes a 75%–85% reduction in
capillary PC coverage compared with heterozygous littermates
(Figure 2A; Armulik et al., 2010; Lindblom et al., 2003). PDGFRb
is still expressed in these mice and can still be used as a marker
for residual pericytes.
We first examined myelination in Pdgfbret/ret mice and found
that, on post-natal day 12 (P12), the density of mature oligoden-
drocytes (Olig2+/APC+) was lower and the density of OPCs
(Olig2+/APC) higher than in control mice. However, on P17,
no differences were observed in OPC differentiation and myeli-
nation (Figure S2).
Following lysolecithin-induced demyelination in the ventral
spinal cord white matter (WM), the number of PDGFRb+
increased substantially in both Pdgfbret/ret and control mice.
The number of PDGFRb+ cells in Pdgfbret/ret mice at 5 dpl was
less than in control mice, and there were fewer PLCs. However,
(C) Proliferating PDGFRb+ cells and ECs (PDGFRb/RECA-1/Ki67) within lesions at 5, 14, and 21 dpl. White arrows indicate proliferating PCs and yellow
arrowheads PLCs.
(D–K) Quantitative analyses of different PC parameters in response to demyelination.
(L) Immunohistochemistry showing the distance of OPCs (Olig2+/APC), mature oligodendrocytes (Olig2+/APC+), and PDGFRb+ at 14 dpl; yellow arrowheads
indicate OPCs and white arrows mature oligodendrocytes. The high-magnification image shows mature oligodendrocytes close to PDGFRb+ cells.
(M) The graph displays the distance distribution of OPCs and mature oligodendrocytes from PDGFRb + cells.
(C–M) 3 or more animals were analyzed for each time point.
(L and M) 150 or more distance measurements were performed from oligodendrocytes to PDGFRb+ cells per animal.
Means ± SEM are shown. Data were analyzed by one-way ANOVA followed by Tukey’s post hoc test, Student’s t test, or chi-square test. *p < 0.05, **p < 0.01,
***p < 0.001. Scale bars, (B) 20 mm; (C) 50 mm; (D) 50 mm, high-magnification 10 mm; (E) 50 mm, high magnification 10 mm.
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Figure 2. OPC Differentiation Is affected during Remyelination in Pdgfbret/ret Mice
(A and B) Illustrations of decreased PC coverage in Pdgfbret/ret mice (A) and of lysolecithin-induced demyelination (B).
(C and J) Mature oligodendrocytes (Olig2+/APC+) and OPCs (Olig2+/APC) in lesions of control and Pdgfbret/ret mice at 14 dpl (C) and 21dpl (J).
(D–G and K–N) Quantitative analyses of oligodendroglia at 14 dpl (D–G) and 21 dpl (K–N).
(H and I) In situ hybridization and quantification for PLP of control and Pdgfbret/ret mice at 14 dpl.
(O and P) Toluidine blue staining of remyelination in control and Pdgfbret/ret mice at 21 dpl (O) and its quantification by relative ranking analysis (P).
Means ± SEM are shown. Data were analyzed by Student’s t test or Mann-Whitney U test. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 100 mm.
1758 Cell Reports 20, 1755–1764, August 22, 2017
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by 14 dpl, the density of PDGFRb+ cells was the same in both
groups because of a higher proliferative response of these cells
in the Pdgfbret/ret mice (Figures S3A–S3F). No differences were
detected in the astrocyte or in the macrophage/microglial
response between Pdgfbret/ret mice and control mice (Figures
S3G–S3I). Microglia/macrophages showed the same pro-in-
flammatory and anti-inflammatory cell profile distribution in
both groups (Figures S3J–S3L), and no differences were de-
tected in BBB stability in the lesion area (Figures S3M–S3Q).
The total number of Olig2+ cells within the lesion was reduced
in Pdgfbret/ret mice compared with controls at 14 dpl. There was
no significant difference in the number of Olig2+/APC OPCs
between Pdgfbret/ret and control mice (Figures 2C and 2E). How-
ever, the number of Olig2+/APC+ mature oligodendrocytes was
significantly reduced in Pdgfbret/retmice (Figures 2C, 2F, and 2G).
In situ hybridization for proteolipid protein (PLP), a major myelin
component, generated consistent results (Figures 2H and 2I).
However, the densities of Olig2+ cells and Olig2+APC+ oligo-
dendrocytes were the same in both groups by 21 dpl (Figures
2J–2N). No differences were detected in the extent of remyelina-
tion, as assessed by ranking analysis of toluidine blue-stained
resin sections in which demyelinated and remyelinated axons
were discernable (Figures 2O and 2P).
These data indicate that Pdgfbret/ret mice show a delay in OPC
differentiation because of the decreased numbers of PDGFRb+
cells at the earlier stages following demyelination. However,
because the PDGFRb+ cell numbers normalize by 14 dpl, this
delay does not translate into a decrease in remyelination.
PCs Promote OPC Differentiation and Enhance
Remyelination Ex Vivo
We next examined how PCs might directly influence OPC func-
tion. We therefore exposed cultured OPCs to PC-conditioned
medium (PC-CM) and evaluated the rate of differentiation.
MSC-conditioned medium (MSC-CM), previously identified as
a strong inducer of OPC differentiation (Jadasz et al., 2013),
was used as a positive control. Primary PCs exhibiting MSCs
features, including mesenchymal differentiation potential, were
isolated from adult rat brains (Figure 3A; Figures S4B–S4D).
Upon incubation with PC-CM, a higher proportion of OPCs had
acquired 2’,30-cyclic-nucleotide 30-phosphodiesterase (CNP)
and myelin basic protein (MBP) expression at 2 days in vitro
(DIV) compared with those exposed to non-conditioned control
medium (Figures 3B–3D). We also found a significantly higher
proportion of NG2+/Olig2+ OPCs in the PC-CM-treated cultures
(Figures 3B and 3E). This effect was likely due to an anti-
apoptotic effect of the PC-CM because PC-CM significantly
decreased the proportion of caspase-3-positive OPCs com-
pared with control conditions (Figure 3F). Proliferation, assessed
by Ki67 staining, was not affected by PC-CM (Figure 3G).
Wenext examinedwhetherPCscanenhance remyelination.We
usedpostnatal rat-derivedcerebellar organotypic slice culturesas
an ex vivo model of remyelination (Yuen et al., 2013; Zhang et al.,
2011). In this model, P10 rat cerebellar slices were demyelinated
using lysolecithin (Birgbauer et al., 2004) and then exposed to
PC-CM or control medium (Figure 3H). Remyelination was
analyzed at 0, 2, 4, 6, and 8 days after lysolecithin treatment by
immunohistochemical staining for MBP and neurofilament heavy
chain (NFH). PC-CM significantly enhanced the remyelination
rate after lysolecithin-induced demyelination (Figures 3I and 3J).
PC-Induced OPC Differentiation Is Mediated through
Lama2
We have previously shown that Lama2 mRNA expression is
decreased in the microvessels of Pdgfbret/ret mice compared
with control mice (Armulik et al., 2010; Figure 4B). The Lama2
gene product is highly expressed during remyelination (Zhao
et al., 2009) and has been shown to modulate OPC function (Re-
lucio et al., 2012). Given that themain source of Lama2within the
microvessels is PDGFRb+ cells, as shown by RNA sequencing
(RNA-seq) (He et al., 2016; Figure 4A), we investigated whether
Lama2 is a mediator of the PC-induced effect on OPC differen-
tiation. RNA in situ hybridization of healthy brain sections
revealed a specific expression of Lama2 in cells expressing the
PC markers PDGFRb and CD13 (Figure 4D). In control mice,
Lama2 was mainly detected around cell bodies and processes
of PCs, whereas Pdgfbret/ret mice had less Lama2 protein
expression that, when present, was always associated with
residual PCs (Figure 4E). Cultured PCs also expressed Lama2
(Figure 4C). Pre-incubation of PC-CM with an anti-Lama2 anti-
body resulted in a significant decrease in the Olig2+/CNP+ and
Olig2+/MBP+ populations compared with PC-CM pre-incu-
bated with a general immunoglobulin G (IgG), reducing OPC
differentiation to a level indistinguishable from control conditions
(Figures 4F and 4G). These results were replicated in OPCs
exposed to PC-CM harvested from PCs treated with either
non-targeting or Lama2 small interfering RNA (siRNA) for 48 hr
(Figures 4H and 4I). Taken together, these data identify Lama2
as a PC-derived molecule that promotes OPC differentiation.
DISCUSSION
This work reveals an unidentified role of PCs in CNS regenera-
tion. We show that PCs in the vessel walls respond to
Figure 3. PCs Promote OPC Differentiation and Accelerate Remyelination in Demyelinated Organotypic Slices
(A) Schematic of the experimental design.
(B–E) Fluorescence images (B) displaying CNP+/Olig2+, MBP+/Olig2+, and NG2+/Olig2+ oligodendrocytes at 4 DIV and their respective graphs (C–E).
(F and G) PC-CM increases the generation of oligodendrocytes from OPCs. Graphs display (F) the OPC survival rate (NG2+/Caspase+) and (G) the OPC
proliferation rate (NG2+/Ki67+) under different conditions.
(H) Illustration of lysolecithin-induced demyelination of slice cultures.
(I) Images showing axons (NFH+) and myelin (MBP+) of remyelinating cerebellar slices exposed to control medium versus PC-CM at 4, 6, and 8 days post
lysolecithin treatment.
(J) Quantification of the MBP/NFH ratio shows that PC-CM increases the remyelination rate. 3 or more independent OPC and slice preparations were used.
Means ± SEM are shown. Data were analyzed by two-way ANOVA followed by Bonferroni’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001. * indicates statistical
difference for PC-CM and # for MSC-CM. Scale bars, (B) 100 mm and (I) 50 mm.
1760 Cell Reports 20, 1755–1764, August 22, 2017
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demyelination by proliferation. We describe a parenchymal cell
population expressing PCmarkers such as PDGFRb and desmin
that appears soon after the induction of demyelination. Although
these cells express PC markers, we cannot be certain of their
origin, and, therefore, we refer to them as PLCs. Upon demyelin-
ation, both PCs and PLCs have a high proliferative response;
however, mature oligodendrocytes are preferentially located in
higher frequency close to PCs. These data suggest that, even
though both populations respond to demyelination, they may
have differential roles in their interaction with OPCs during re-
myelination, which will require further investigation. In mice
with a reduced PC density, OPC differentiation is delayed in
the demyelinated lesion, resulting in fewer mature oligodendro-
cytes at 14 dpl. Moreover, exposure to PC-CM accelerated
OPC differentiation and enhanced ex vivo remyelination. We
identified Lama2 as a key factor responsible for the effect of
PCs in promoting OPC differentiation.
In humans, loss of LAMA2 gene expression causes WM
abnormalities, manifested at an early postnatal age, when devel-
opmental myelination occurs (Allamand and Guicheney, 2002).
Similarly, a mouse model for Lama2 deficiency (Lama2/)
shows developmental delays in oligodendrocyte differentiation
and the accumulation of OPCs, leading to defects in myelination
in the corpus callosum (Chun et al., 2003; Relucio et al., 2012).
Lama2 regulates OPC function through its interaction with dys-
troglycan (Leiton et al., 2015). In the CNS, Lama2 is expressed
by PCs and upregulated during OPC differentiation (14 dpl) in a
toxin-induced demyelination model (Zhao et al., 2009). Lama2
seems to be relevant for PC function because Lama2/ mice
have decreased microvascular PC coverage associated with
BBB defects (Menezes et al., 2014). Our data suggest that PC-
derived Lama2 has a key role in promoting OPC differentiation
because the PC-CM effect in OPCs was inhibited when exposed
to an anti-Lama2 antibody or when PCswere treated with Lama2
siRNA. Consistent with this, we observed that OPC differentia-
tion was delayed in adult Pdgfbret/ret mice after lysolecithin-
induced demyelination. These findings indicate that PCs provide
an appropriate milieu for differentiating OPCs through Lama2.
This study indicates that PC functions are not restricted to
vascular homeostasis but, rather, extend to CNS regeneration.
This is supported by studies illustrating that PCs respond with
high proliferation to acute lesions such as stroke or spinal cord
injury (SCI), where they modulate inflammation or the formation
of fibrotic scar tissue (Go¨ritz et al., 2011; O¨zen et al., 2014).
Here we show that, besides stabilizing CNS vasculature and
regulating EC function, pericytes also have a high proliferative
response following CNS demyelination and directly influence
CNS-resident progenitor cell differentiation during remyelina-
tion, most likely by secretion of Lama2.
EXPERIMENTAL PROCEDURES
Animal Work
Animal experiments within this research have been regulated under the
Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012
following ethical review by the University of Cambridge Animal Welfare
and Ethical Review Body (AWERB) in accordance with United Kingdom
Home Office regulations (Project License 70/7715) and in accordance with
Austrian laws on animal experimentation and were approved by Austrian
regulatory authorities (Permit No. BMWF-66.012/0001-II/3b/2014; license
codes BMBF-66-012/0037-WF/V/3b/2014 and BMWF-66.012/0032-WF/V/
3b/2015). During this study, 2- to 3-month-old Sprague Dawley rats and 12-
week-old Pdgfbret/ret mice (hetero- and homozygous), which were previously
described by Armulik et al. (2010) and Lindblom et al. (2003), were used for
toxin-induced demyelination.
Cell Culture
Preparation of CNS pericytes was performed following the Dore-Duffy proto-
col (Dore-Duffy et al., 2006) with modifications. Rat bone marrow-derived
MSCs were prepared as described previously by Rivera et al. (2006). OPCs
were prepared from neonatal P0–P2 Sprague-Dawley rats, cortices and hippo-
campi were digested with papain solution, and dissociated cells were seeded
into poly-D-lysine-coated T75 flasks. Mixed glial cultures were kept for 11 DIV
in medium with DMEM (Gibco) and 10% fetal bovine serum (Biosera). OPCs
were isolated as described previously (McCarthy and de Vellis, 1980).
Organotypic Cerebellar Slices
Remyelination of rat cerebellar slices was prepared as described previously
(Birgbauer et al., 2004). After 7 DIV, themediumwas replacedwith organotypic
slice medium containing 0.5 mg/mL lysolecithin for 16 hr. After 16 hr, the
medium was replaced with PC-conditioned organotypic slice medium and
non-conditioned control medium.
Statistical Analyses
Graphs show mean values ± SEM, and statistical analysis were performed
using GraphPad Prism 5.0 (GraphPad) and SPSS 20 (IBM). Parametric one-
way ANOVA, Tukey post hoc analyses, Student’s t test, or Mann-Whitney
U tests (when not normally distributed) were used when comparing one
parameter. For statistical analysis with two parameters, such as time course
experiments with different treatments, two-way ANOVA with Bonferroni post
hoc was used. For distance frequency distribution analysis, chi-square test
Figure 4. PC-Derived Lama2 Promotes OPC Differentiation and Is Decreased in Pdgfbret/ret Mice
(A) RNA-seq data showing the expression of Lama2 in the microvasculature (mainly consisting of a majority of ECs with very low PC contribution) versus sorted
PCs (data extracted from He et al., 2016).
(B) Downregulation of Lama2 in microvessels of Pdgfbret/ret mice (Affymetrix array data extracted from He et al., 2016).
(C) Western blot image indicating Lama2 expressed by PCs in vivo (brain) and in vitro.
(D) RNA in situ hybridization images showing PC-specific expression of PDGFRb, CD13, and Lama2.
(E) Confocal images of CD31/PDGFRb-GFP/Lama2/desmin of Pdgfbret/+3 Pdgfrb-EGFP mice compared with Pdgfbret/ret 3 Pdgfrb-EGFP indicate PC-specific
expression of Lama2 and show a decline of PCs and Lama2 in Pdgfbret/ret mice. Boxed areas represent high-magnification images.
(F) Fluorescence images of oligodendrocytes (Olig2+/MBP+) 2 DIV with control medium, PC-CM with IgG, and PC-CM with anti-Lama2-blocking antibody.
(G) Graph displaying the percentage of Olig2+/MBP+ cells.
(H) Fluorescence images of OPCs in control medium, PC- CM from non-targeting siRNA, and PC Lama2 siRNA-treated-CM.
(I) Graph displaying theOlig2+/MBP+ cell population in the presence of the different siRNA-treated PC-CMs. n = 4mice per group, and 3 ormore independent cell
preparations were used, except for siRNA experiments, where n = 2.
Means ± SEM are shown. Data were analyzed by Student’s t test or one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001. Scale
bars, (C) 5 mm; (D) 100 mm, high-magnification 10 mm; (E) and (G), 50 mm.
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was used (Figure 1M; Figures S1G and S1H). All experiments were performed
as indicated by n in the figure legends. Significance was as follows: p* < 0.05,
p** < 0.01, and p*** < 0.001.
For further details, see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2017.08.007.
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